AnaptysBio, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
29.9M
on 2026-09-16, from 27.3M on 2024-03-31 10-KT ↗
a raise that quarter, at its price
Newest
S-3 of 2024-11-05. Not read yet. S-3 ↗
5 of its filings are not read yet.
Warrants
No warrant count read from a 10-Q or 10-K.
Cash
$164.1M
Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-KT ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-03-27 | Private placement | 4,705,576 | $13.81 | not stated | 8-K ↗ |